“Permission Will Be Given After Seeing The Report”: AYUSH Minister Shripad Naik On Patanjali COVID19 Medicine
Mumbai: MOS for Union AYUSH Minister Shripad Naik said on Wednesday that his ministry will clear its stance on pharmaceutical giant Patanjali’s newly launched Ayurvedic medicines ‘Coronil and Savori’.
However, the minister said that it is good that Baba Ramdev has given the country a new medicine.
“It is a good thing that Baba Ramdev has given the country a new medicine, but as per the rule, first one has to come to the AYUSH ministry. They even said that they have sent a report. We will look into it and permission will be given after seeing the report,” Naik told ANI.
The Ministry of AYUSH on Tuesday said that it has taken cognizance of the media reports about Ayurvedic medicines developed by Patanjali Ayurved Ltd in Haridwar for the treatment of COVID-19 and said the company has been asked to “stop advertising/publicizing such claims till the issue is duly examined”.
In a release, the ministry said that the facts and claims of the mentioned scientific study are not known.
It had stated that the concerned Ayurvedic drug manufacturing company has been informed that such advertisements for medicines including Ayurvedic medicines are regulated under the provisions of the Drugs and Magic Remedies (Offensive Advertisement) Act, 1954 and by the Central Government in view of the COIDID outbreak Issued instructions.
The release stated that Patanjali Ayurveda has been asked to provide a preliminary description of the names and composition of the drugs claimed for COVID treatment, places where research studies are being conducted on COVID-19, protocols, sample sizes, institutional ethics. The committee was organized. Withdrawal, CTRI registration, and the results of the study’s data and “stop advertising / promoting such claims until the problem is duly investigated”.
Patanjali Ayurved on Tuesday launched ‘Coronil and Swasari’ claiming it to be Ayurvedic cure for treating COVID-19 and said clinical trials have shown favorable results.
Follow us on Twitter, Instagram, and like us on Facebook for the latest updates and interesting stories.
